These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35195592)

  • 1. Larger Volume and Higher Fat Content of the Pancreatic Head Are Predictive Factors for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Shintani S; Inatomi O; Bamba S; Takeda Y; Fujimoto T; Ota S; Tsuji Y; Kutsumi H; Watanabe Y; Andoh A
    Pancreas; 2022 Jan; 51(1):28-34. PubMed ID: 35195592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of pancreatic volume quantitative analysis as a predictor of development and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Akazawa Y; Ohtani M; Nosaka T; Takahashi K; Naito T; Matsuda H; Nakamoto Y
    Pancreatology; 2024 Aug; 24(5):698-705. PubMed ID: 38879434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
    J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pancreatic fat on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Chung MJ; Park DH; Min S; Park SW
    Surg Endosc; 2022 Aug; 36(8):5734-5742. PubMed ID: 35099627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Need for pancreatic stenting after sphincterotomy in patients with difficult cannulation.
    Nakahara K; Okuse C; Suetani K; Michikawa Y; Kobayashi S; Otsubo T; Itoh F
    World J Gastroenterol; 2014 Jul; 20(26):8617-23. PubMed ID: 25024617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for post-ERCP pancreatitis in pancreas divisum patients without chronic pancreatitis.
    Meng QQ; Zhao SB; Wang ZJ; Shen Z; Xia T; Wang SL; Gu L; Pan P; Li ZS; Yao J; Shi YH; Bai Y
    Scand J Gastroenterol; 2020 Jun; 55(6):732-736. PubMed ID: 32567400
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) abdominal pain in patients without post-ERCP pancreatitis.
    Chen MJ; Zheng RH; Cao J; Yao YL; Wang L; Zou XP
    Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):285-292. PubMed ID: 34924299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients.
    Miyatani H; Matsumoto S; Mashima H
    J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of double-guidewire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.
    Ito K; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Koshita S; Kanno Y; Ogawa T; Masu K; Hashimoto S
    Dig Endosc; 2014 May; 26(3):442-9. PubMed ID: 23937334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases.
    Chi JY; Ma LY; Zou JC; Ma YF
    BMC Surg; 2023 Mar; 23(1):62. PubMed ID: 36959589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of changing our cannulation method on the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement.
    Hisa T; Matsumoto R; Takamatsu M; Furutake M
    World J Gastroenterol; 2011 Dec; 17(48):5289-94. PubMed ID: 22219598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
    Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of pancreatitis after pancreatic duct guidewire placement during endoscopic retrograde cholangiopancreatography.
    Ishikawa-Kakiya Y; Shiba M; Maruyama H; Kato K; Fukunaga S; Sugimori S; Otani K; Hosomi S; Tanaka F; Nagami Y; Taira K; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y
    PLoS One; 2018; 13(1):e0190379. PubMed ID: 29320523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Park SW; Yang MJ; Moon SH; Park DH
    Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Into which Region Should a Prophylactic Pancreatic Stent Be Inserted? A Propensity Score Matching Analysis.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Nakamura J; Takasumi M; Hashimoto M; Kato T; Hikichi T; Ohira H
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):399-405. PubMed ID: 32830824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.